BIO-key International, Inc. (NASDAQ:BKYI) has a beta value of 1.42 and has seen 227,507 shares traded in the last trading session. The company, currently valued at $15.68 Million, closed the last trade at $0.74 per share which meant it lost $0 on the day or -2.76% during that session. The BKYI stock price is -248.65% off its 52-week high price of $2.58 and 52.7% above the 52-week low of $0.35. If we look at the company’s 10-day average daily trading volume, we find that it stood at 541.74 Million shares traded. The 3-month trading volume is 2.28 Million shares.

The consensus among analysts is that BIO-key International, Inc. (BKYI) is a Hold stock at the moment, with a recommendation rating of 3. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 1 have rated it as a Hold, with no one of them advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.06.

BIO-key International, Inc. (NASDAQ:BKYI) trade information

Despite being -2.76% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Friday, May 29 when the BKYI stock price touched $0.82 or saw a rise of 9.88%. Year-to-date, BIO-key International, Inc. shares have moved 47.8%, while the 5-day performance has seen it change -4.65%. Over the past 30 days, the shares of BIO-key International, Inc. (NASDAQ:BKYI) have changed -32.2%. Short interest in the company has seen 45.14 Million shares shorted with days to cover at 19.8.

Wall Street analysts have a consensus price target for the stock at $2, which means that the shares’ value could jump 170.27% from current levels. The projected low price target is $2 while the price target rests at a high of $2. In that case, then, we find that the current price level is +170.27% off the targeted high while a plunge would see the stock lose 170.27% from current levels.

BIO-key International, Inc. (BKYI) estimates and forecasts

Figures show that BIO-key International, Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +34.49% over the past 6 months, with this year growth rate of NA%, compared to NA% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 14.3% and 57.1% for the next quarter. Revenue growth from the last financial year stood is estimated to be +144.3%.

1 analysts offering their estimates for the company have set an average revenue estimate of $530Million for the current quarter. 1 have an estimated revenue figure of $1.57 Million for the next quarter concluding in June 01, 2020. Year-ago sales stood $1.9 Million and $728Million respectively for this quarter and the next, and analysts expect sales will grow by -72.1% for the current quarter and 115.7% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +-21.8% over the past 5 years. Earnings growth for 2020 is a modest +-40.1% while over the next 5 years, the company’s earnings are expected to increase by 0%.